Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dietary Supplements to Reduce Symptom Severity and Duration in People With SARS-CoV-2: A Randomized, Double Blind, Placebo Controlled Clinical Trial

NCT04780061 is registered in ClinicalTrials.gov with The Canadian College of Naturopathic Medicine as lead sponsor.

NCT NCT04780061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04780061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dietary Supplements to Reduce Symptom Severity and Duration in People With SARS-CoV-2: A Randomized, Double Blind, Placebo Controlled Clinical Trial
Lead sponsor
The Canadian College of Naturopathic Medicine
Phase
Phase 3
Overall status
Terminated
Start date
July 12, 2021
Completion date
July 7, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19